Adefovir

Adefovir

SCHEMBL29365535

Nc1ncnc2c1ncn2CCOCP(=O)(O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

P

The experimentally established mechanism targets of Adefovir. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 3/20 1.00
SLC22A6 Q4U2R8 2/20 1.00
ABCB11 O95342 1/20 0.62
POLA1 P09884 1/20 0.62
POLG P54098 1/20 0.62
FAP Q12884 1/20 0.62
CYP3A4 P08684 1/20 0.62
ENPP1 P22413 1/20 0.60
ADORA2A P29274 3/20 0.58
ADORA1 P30542 2/20 0.58
ADCY5 O95622 1/20 0.55
ADORA2B P29275 1/20 0.55
NSD3 Q9BZ95 5/20 0.54
NSD2 O96028 4/20 0.54
LMNA P02545 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adefovir SCHEMBL49373 1.00 FGFR1 (1.00) FGFR1SLC22A6ABCB11POLA1POLG
Adefovir SCHEMBL28511793 0.99 FGFR1 (0.97) FGFR1SLC22A6ABCB11POLA1POLG
Adefovir SCHEMBL28571494 0.99 FGFR1 (0.97) FGFR1SLC22A6ABCB11POLA1POLG
Adefovir SCHEMBL29115272 0.99 FGFR1 (0.97) FGFR1SLC22A6ABCB11POLA1POLG
Adefovir SCHEMBL3639260 0.99 FGFR1 (0.97) FGFR1SLC22A6ABCB11POLA1POLG
Adefovir SCHEMBL439995 0.99 FGFR1 (0.97) FGFR1SLC22A6ABCB11POLA1POLG
Adefovir SCHEMBL28765885 0.99 FGFR1 (0.97) FGFR1SLC22A6ABCB11POLA1POLG
Adefovir SCHEMBL3643715 0.99 FGFR1 (0.97) FGFR1SLC22A6ABCB11POLA1POLG
Adefovir SCHEMBL29064626 0.99 FGFR1 (0.97) FGFR1SLC22A6ABCB11POLA1POLG
Adefovir SCHEMBL439994 0.95 FGFR1 (0.91) FGFR1SLC22A6ABCB11POLA1POLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 571 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122042499-A Sealing pressure measuring hole device capable of replacing sensor cavity and gallery monitoring method 中国水利水电科学研究院 2026-05-15 CN claimed
US-20260131049-A1 RESIN COMPOSITION, MEDICAL MATERIAL, AND METHOD FOR PRODUCING RESIN COMPOSITION NATIONAL UNIV CORPORATION TOKYO UNIV OF AGRICULTURE AND TECHNOLOGY (JP) 2026-05-14 US claimed
EP-4722714-A1 SIMULTANEOUS ANALYSIS OF FOOD-BORNE DOPING SUBSTANCES USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (VFD: VACCINE FOR FOODBORNE DOPING) Korea Institute of Science and Technology (KR) 2026-04-08 EP claimed
US-12584991-B2 UWB-based in-vehicle 3D localization of mobile devices GM Global Technology Operations LLC (US) 2026-03-24 US claimed
US-12497435-B2 Multimerization of IL-15/IL-15R-alpha-fc complexes to enhance immunotherapy MEMORIAL SLOAN KETTERING CANCER CENTER (US) 2025-12-16 US claimed
US-12447445-B2 Porous separation membrane TORAY INDUSTRIES, INC. (JP) 2025-10-21 US claimed
US-12331302-B2 Fungal autoinducible expression system THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-06-17 US claimed
CN-114372343-B Photovoltaic array local shadow detection and mismatch degree estimation method 河海大学常州校区 2025-06-03 CN claimed
WO-2025109441-A1 METHOD OF DETERMINING THE STATE OF POWER OF A TRACTION BATTERY OF AN ELECTRIC VEHICLE, CORRESPONDING SYSTEM, VEHICLE AND COMPUTER PROGRAM PRODUCT MASERATI S.P.A. (IT) 2025-05-30 WO claimed
CN-120011986-A Electricity larceny behavior identification method based on terminal data tide characteristics 国网浙江省电力有限公司绍兴供电公司 2025-05-16 CN claimed
EP-3903855-B1 BLOOD PURIFICATION DEVICE AND EXTRACORPOREAL BLOOD CIRCULATION SYSTEM PROVIDED WITH BLOOD COMPONENT ADJUSTER ASAHI KASEI MEDICAL CO LTD (JP) 2022-10-26 EP claimed
CN-114720988-A Single hydrophone low-frequency broadband matching field distance measuring method based on modal phase 西北工业大学 2022-07-08 CN claimed
CN-112698270-B Design method of unidirectional acoustic array with broadband constant main beam 中国铁路设计集团有限公司 2022-06-24 CN claimed
CN-114519752-A High-resolution fast-calculation passive ultrasonic imaging method and system 西安交通大学 2022-05-20 CN claimed
CN-114447971-A Super capacitor and battery hybrid energy storage device with general applicability 力容新能源技术(天津)有限公司 2022-05-06 CN claimed
CN-114372343-A Photovoltaic array local shadow detection and mismatch degree estimation method 河海大学常州校区 2022-04-19 CN claimed
US-20220106375-A1 MULTIMERIZATION OF IL-15/IL-15R-ALPHA-FC COMPLEXES TO ENHANCE IMMUNOTHERAPY MEMORIAL SLOAN KETTERING CANCER CENTER (US) 2022-04-07 US claimed
CN-113028493-B Online matching and adjusting method for heating load and heat demand of regional heating system 西安交通大学 2022-04-05 CN claimed
CN-112890790-B Wearable noninvasive dynamic blood pressure tracking and monitoring method 浙江大学 2022-03-15 CN claimed
US-20220062522-A1 EXTRACORPOREAL BLOOD CIRCULATION SYSTEM PROVIDED WITH BLOOD PURIFICATION DEVICE AND BLOOD COMPONENT ADJUSTER ASAHI KASEI MEDICAL CO., LTD. (JP) 2022-03-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12584991-B2 UWB-based in-vehicle 3D localization of mobile devices KIF18B, KIF15, KIF18A FGFR1 2084/4885SLC22A6 3126/4885ABCB11 3888/4885
US-20260131049-A1 RESIN COMPOSITION, MEDICAL MATERIAL, AND METHOD FOR PRODUCING RESIN COMPOSITION FGB, ARGLU1, GLMN FGFR1 381/4885SLC22A6 4201/4885ABCB11 3096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.